Profile data is unavailable for this security.
About the company
HENANTALOPHPHARMACEUTICALSTOCKCO., LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company provides oral solutions, transfusion and tablets, which are applied in the treatment of cold, diabetes and virus infection. The Company's main products include Shuanghuanglian oral liquid products, double gold agents, Haberffine tablets and compound Yimu oral solutions, among others. The Company distributes its products mainly within domestic market.
- Revenue in CNY (TTM)2.01bn
- Net income in CNY61.13m
- Incorporated1998
- Employees2.35k
- LocationHenan Taloph Pharmaceutical Stock Co LtdNo. 8Jinsuo RoadHi-Tech Industrial Development ZoneZHENGZHOU 450001ChinaCHN
- Phone+86 37 167992262
- Fax+86 37 167993600
- Websitehttp://www.taloph.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hinova Pharmaceuticals Inc | 0.00 | -266.00m | 2.96bn | 179.00 | -- | 2.23 | -- | -- | -2.69 | -2.69 | 0.00 | 13.39 | 0.00 | 105.68 | -- | 0.00 | -17.03 | -31.86 | -18.39 | -37.18 | -- | -- | -- | -25,578.24 | 11.83 | -- | 0.0097 | -- | -100.00 | -- | 2.44 | -- | 124.37 | -- |
Novoprotein Scientific Inc | 136.28m | -927.60k | 2.98bn | 579.00 | -- | 1.36 | -- | 21.89 | -0.0132 | -0.0132 | 1.94 | 31.19 | 0.0585 | 0.4493 | 1.67 | 235,364.30 | -0.0398 | -- | -0.0409 | -- | 70.17 | -- | -0.6807 | -- | 34.49 | -- | 0.0353 | -- | -42.09 | -- | -85.84 | -- | -- | -- |
Henan Taloph Pharmaceutical Stock Co Ltd | 2.01bn | 61.13m | 3.09bn | 2.35k | 52.56 | 1.89 | -- | 1.54 | 0.1024 | 0.1024 | 3.51 | 2.84 | 0.556 | 3.30 | 2.13 | 853,677.20 | 1.72 | 0.272 | 3.55 | 0.4981 | 26.76 | 27.97 | 3.09 | 0.5501 | 0.9283 | 2.02 | 0.3637 | 28.70 | 5.57 | 11.62 | 160.32 | -- | -8.27 | -- |
Ningbo Menovo Pharmaceutical Co Ltd | 1.23bn | -17.82m | 3.14bn | 2.35k | -- | 1.47 | -- | 2.55 | -0.0997 | -0.0997 | 5.23 | 9.99 | 0.2811 | 1.31 | 6.18 | 523,989.50 | -0.3253 | 4.94 | -0.4782 | 7.83 | 30.72 | 35.39 | -1.16 | 13.71 | 0.7935 | 0.7647 | 0.4042 | 10.78 | -16.51 | 7.46 | -96.58 | -34.53 | -6.03 | -32.54 |
Chemclin Diagnostics Co Ltd | 450.62m | 154.61m | 3.19bn | 658.00 | 20.62 | 2.34 | -- | 7.08 | 0.3856 | 0.3856 | 1.12 | 3.40 | 0.2778 | 1.01 | 14.57 | 684,836.00 | 9.53 | 2.37 | 10.67 | 2.63 | 73.89 | 73.64 | 34.31 | 5.92 | 5.16 | -- | 0.1075 | 161.02 | -1.17 | 7.87 | 6.91 | -- | 16.09 | -- |
Cabio Biotech Wuhan Co Ltd | 473.06m | 101.38m | 3.20bn | 508.00 | 31.97 | 2.13 | -- | 6.76 | 0.594 | 0.594 | 2.77 | 8.92 | 0.2948 | 2.49 | 2.27 | 931,222.90 | 6.01 | 7.81 | 6.55 | 8.34 | 41.34 | 46.96 | 20.40 | 28.65 | 6.19 | -- | 0.008 | 39.86 | 2.39 | 9.18 | 41.95 | -1.19 | 89.01 | -- |
Data as of Apr 18 2024. Currency figures normalised to Henan Taloph Pharmaceutical Stock Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 1.87m | 0.33% |
Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 913.00k | 0.16% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 625.58k | 0.11% |
GF Fund Management Co., Ltd.as of 30 Jun 2023 | 417.60k | 0.07% |
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023 | 142.70k | 0.03% |
Yinhua Fund Management Co., Ltd.as of 30 Jun 2023 | 68.40k | 0.01% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.